ﺑﺎﺯﮔﺸﺖ ﺑﻪ ﺻﻔﺤﻪ ﻗﺒﻠﯽ
خرید پکیج
تعداد آیتم قابل مشاهده باقیمانده : -7 مورد

Guidelines for imaging for Ewing sarcoma family of tumors from the Children's Oncology Group

Guidelines for imaging for Ewing sarcoma family of tumors from the Children's Oncology Group
At presentation and prior to local control
Site Testing
Primary and bone metastases AP and lateral radiographs
Primary tumor MRI with gadolinium (presurgery exam should be performed within four weeks of local control procedure)
Bone metastases MRI with gadolinium or CT scan with contrast (recommended for possible bone metastases if diagnosis uncertain)
Chest CT without contrast
Whole body FDG-PET/CT (recommended at presentation, particularly if primary bone tumor negative on bone scintigraphy)
Baseline after local treatment
Site Testing and timing
Primary and bone metastases AP and lateral radiographs within two weeks of surgery
Primary tumor MRI with gadolinium or CT scan with IV contrast (in patients without significant metallic artifact at primary tumor site) three to four months after local control
Bone metastases MRI with gadolinium or CT scan with contrast (recommended for possible bone metastases if diagnosis uncertain)
Surveillance on chemotherapy
Site Testing and timing
Primary and bone metastases

AP and lateral radiographs after 10 cycles (approximately halfway through postoperative chemotherapy)

MRI with gadolinium or CT scan with IV contrast recommended if symptoms or abnormal imaging (and surgical intervention or radiation therapy contemplated)
Chest CT without contrast after 10 cycles (approximately halfway through postoperative chemotherapy)
Whole body FDG-PET/CT (if disease positive on prior FDG-PET/CT and bone scan-negative) recommended or PET/MRI
  • At end of cytotoxic chemotherapy
  • Sooner if symptoms or abnormal imaging (and surgical or other intervention contemplated)
Surveillance postchemotherapy
Site Testing and timing
Primary and bone metastases

AP and lateral radiographs every three months × 8, then every six months × 6, then every 12 months × 5

MRI with gadolinium or CT scan with IV contrast recommended if symptoms or abnormal imaging (and surgical or other intervention contemplated)
Chest CT without contrast every three months × 8, then every six months × 6, then every 12 months × 5
Whole body FDG-PET/CT (if positive on prior scans and bone scan-negative) if symptoms or abnormal imaging and surgical or other intervention contemplated
AP: anterior-posterior; CT: computed tomography; FDG-PET: fluorodeoxyglucose positron emission tomography; IV: intravenous; MRI: magnetic resonance imaging.
Reference:
  1. Cederberg KB, Iyer RS, Chaturvedi A, et al. Imaging of pediatric bone tumors: A COG Diagnostic Imaging Committee/SPR Oncology Committee White Paper. Pediatr Blood Cancer 2023; 70:e30000.
Graphic 68393 Version 10.0